About VectorBuilder
VectorBuilder is a Healthcare company based in Chicago (United States) founded in 2014. Custom vector design, cloning, and virus packaging are offered online. VectorBuilder has raised $57.15 million across 1 funding round from investors including Xiamen C&D Metals, Legend Capital and Yuexiu Capital. The company has 107 employees. VectorBuilder was last valued at $1 billion in December 2023. Its website vectorbuilder.com draws about 127 thousand monthly visits. Its focus areas include Biopharma Outsourcing, CDMO, Biologics and Cell and Gene Therapy. Its competitors include Genezen, Oxford Biomedica Solutions and Ascend; 1 of its 3 listed competitors has raised funding.
Company details
VectorBuilder was founded in 2014 in Chicago, United States, within the biotechnology sector. An online platform is maintained for vector design, custom cloning, and virus packaging services. These encompass lentivirus, adenovirus, adeno-associated virus (AAV), MMLV, and piggyBac systems. Operations focus on facilitating research and development needs for scientific applications across global users.
- Total Equity Funding$57.15M (USD)
in 1 rounds
- Latest Funding Round$57.15M (USD), Series C
Oct 2022
- InvestorsXiamen C&D Metals
& 4 more
- Employee Count107
Apps and channels of VectorBuilder
its YouTube channel VectorBuilder Inc. has 1.13K subscribers and 30 videos.
Videos from VectorBuilder
The most watched videos on VectorBuilder's YouTube channel, VectorBuilder Inc. (1.13K subscribers). Click a video to play it here.
More on VectorBuilder Inc..
Funding Insights of VectorBuilder
VectorBuilder has successfully raised a total of $57.15M through 1 strategic funding round. The most recent funding activity was a Series C round of $57.15 million completed in October 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $57.15M
- Total Rounds 1
- Last Round Series C — $57.15M
- First Round $57.15M
(Oct 2022)
- Investors Count 5
All 1 funding rounds of VectorBuilder with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2022 | $57.15M | Series C | – | Legend Capital |
Last known valuation $1B (Dec 2023). 5 investors in total: 5 institutional.
Investors in VectorBuilder
VectorBuilder has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Xiamen C&D Metals, Legend Capital and Yuexiu Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture Capital firm focused on multiple sectors | legendcapital.com.cn | Haidian, China | ||
Yuexiu Capital is engaged in financial services and asset management. | yuexiufund.com | Guangzhou, China | ||
| cctgroup.com.cn | ||||
Supply chain, real estate, and financial services are provided. | 1980 | chinacnd.com | Xiamen, China | |
| wlzq.cn |
Investor details for VectorBuilder
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of VectorBuilder
13 people are tracked at VectorBuilder (3 in leadership, 10 in team); the tracked headcount is 107.
| Name | Role | Group |
|---|---|---|
Kristofer Müssar | Managing Director Of Vectorbuilder Gmbh | Leadership |
Jason Ye | Chief Technology Officer | Leadership |
Bruce Lahn | Chief Scientist | Leadership |
Croydon Fernandes | Marketing Manager | Team |
Vectorbuilder Careers | Human Resources Manager | Team |
Luke Wang (Lei) | Application Scientist | Team |
Auguste Attenot | Account Manager | Team |
堂鑫 高 | Application Scientist | Team |
Brady Strittmatter | Application Scientist | Team |
Kimberly Salinas | Human Resources Associate | Team |
Tracy Zhong | Marketing And Product Management | Team |
Dongye Liu (Dora) | Marketing And Product Development Specialist | Team |
Olivier Petitjean | Regional Sales Manager (fr/be/ch/lu) | Team |
Complete people profiles for VectorBuilder
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of VectorBuilder
2 dated milestones of VectorBuilder across 8 years, from founding to its latest funding, stage changes and deals.
- Founded VectorBuilder is founded.
- Funding First funding round of $57.2M.
Competitors of VectorBuilder
VectorBuilder has 3 listed competitors in our database, 1 of them funded. They include Genezen, Oxford Biomedica Solutions and Ascend.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genezen.com | 2014 | Indianapolis, United States | CDMO focused on manufacturing of viral vector products | |||
| oxbsolutions.com | 2022 | Bedford, United States | Oxford Biomedica Solutions is a CDMO focused on manufacturing AAV cell and gene therapy products. | |||
| useascend.com | 2021 | Palo Alto, United States | $35.5M | 39 | Online insurance payments and premium financing are enabled for businesses. |
Detailed competitors of VectorBuilder
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of VectorBuilder
The website of VectorBuilder (vectorbuilder.com) receives about 127.2K visits a month.
- Monthly visits127.2K
▼ 5% vs previous month
Websites whose visitors overlap most with VectorBuilder. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
addgene.org | addgene.org | 100% | #84,256 | – | |
| idtdna.com | 100% | 505.8K | #85,096 | View details | |
premierbiosoft.com | premierbiosoft.com | 99% | #1,258,936 | – | |
| benchling.com | 99% | 1.4M | #36,159 | View details | |
| twistbioscience.com | 96% | 167.6K | #226,348 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for VectorBuilder
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as VectorBuilder (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vectorbuilder
Complete news archive for VectorBuilder
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VectorBuilder
VectorBuilder was founded in 2014 and raised its 1st funding round 8 years after it was founded.
VectorBuilder is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.
VectorBuilder is a funded company, having raised a total of $57.15M across 1 funding round to date. The company's 1st funding round was a Series C of $57.15M, raised on Oct 2022.
VectorBuilder has 107 employees.
VectorBuilder was founded in 2014 in Chicago, United States, within the biotechnology sector. An online platform is maintained for vector design, custom cloning, and virus packaging services. These encompass lentivirus, adenovirus, adeno-associated virus (AAV), MMLV, and piggyBac systems. Operations focus on facilitating research and development needs for scientific applications across global users.
VectorBuilder's top competitors include Ascend, Genezen and Oxford Biomedica Solutions.
VectorBuilder has 5 investors. Key investors include Xiamen C&D Metals, Legend Capital, Yuexiu Capital, China Chengtong, and Wanlian Tianze.
The valuation of VectorBuilder is $1B as of Dec 2023.
The website of VectorBuilder receives about 127 thousand visits a month.